Digestive System Neoplasms
Showing 1 - 25 of >10,000
Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)
Recruiting
- Digestive System Neoplasms
- iNeo-Vac-R01
-
Hangzhou, Zhejiang, ChinaDepartment of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023
Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)
Recruiting
- Digestive System Neoplasms
- iNeo-Vac-R01 in combination with standard adjuvant therapy
-
Hangzhou, Zhejiang, ChinaDepartment of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023
Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)
Recruiting
- Digestive System Neoplasms
- iNeo-Vac-R01
-
Hangzhou, Zhejiang, ChinaDepartment of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023
Body Composition and Digestive System Cancer Survival
Active, not recruiting
- Digestive System Cancer
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)
Recruiting
- Digestive System Cancers
- KN046
- +2 more
-
Beijing, ChinaPeking University Cancer Hospital
Oct 25, 2023
Advanced Solid Tumors, Digestive System Tumors, Pancreatic Cancer Resectable Trial in Beijing (IM96 CAR-T cells)
Recruiting
- Advanced Solid Tumors
- +3 more
- IM96 CAR-T cells
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Mar 10, 2022
Malignant Tumors of the Digestive System, Trombocitopenia Trial in Wuhan (Hetrombopag Olamine)
Recruiting
- Malignant Tumors of the Digestive System
- Trombocitopenia
- Hetrombopag Olamine
-
Wuhan, Hubei, Chinaxianglin Yuan
Oct 7, 2022
Esophageal Tumors, Esophageal Diseases, Digestive System Tumors Trial (Camrelizumab, Paclitaxel, Platinum)
Not yet recruiting
- Esophageal Neoplasms
- +2 more
- Camrelizumab
- +3 more
- (no location specified)
Nov 20, 2022
Digestive Tumor Trial (TM4SF1-positive chimeric antigen receptor T-cell therapy)
Not yet recruiting
- Digestive Tumor
- TM4SF1-positive chimeric antigen receptor T-cell therapy
- (no location specified)
Dec 21, 2022
Stomach Tumors, Digestive System Tumors, Tumors Trial in Fuzhou (Camrelizumab, SOX, Surgery)
Active, not recruiting
- Stomach Neoplasms
- +5 more
- Camrelizumab
- +2 more
-
Fuzhou, Fujian, ChinaThe Second Affiliated Hospital of Fujian Medical University
Nov 1, 2022
Advanced Digestive System Tumor Trial in China (IMC001 injection)
Not yet recruiting
- Advanced Digestive System Tumor
- IMC001 injection
-
Beijing, Beijing, China
- +6 more
Jul 12, 2023
A Population-based, Multicenter Cohort Study of Combined
Not yet recruiting
- Digestive Disease
- Gastroenteroscopy；Risk factor investigation; FIT-HP;RNF180 and SEPTIN9 gene methylation test
- Risk factor investigation;
- (no location specified)
Aug 10, 2023
Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)
Recruiting
- Carcinoma
- +4 more
- Pemigatinib
- PD-1 Inhibitors
-
Guangzhou, Guangdong, ChinaLei Zhang
Jun 21, 2023
Fibroblast Activation Protein Inhibitor PET/CT Imaging in
Recruiting
- Gastrointestinal Cancer
- Fibroblast activation protein inhibitor PET/CT imaging
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 14, 2022
Cancer, Digestive System, Cancer, Rectum Trial in Ostrava (Physical training, Muscle strength training)
Recruiting
- Cancer, Digestive System
- Cancer, Rectum
- Physical training
- Muscle strength training
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Dec 12, 2022
Hypothermia After Laparoscopic Gastrointestinal Tumor Surgery
Not yet recruiting
- Hypothermia; Anesthesia
- The tympanic membrane temperature of patients was measured.
- (no location specified)
Jul 20, 2023
Gastrointestinal Tumors Trial (Anti-allergic treatment)
Not yet recruiting
- Gastrointestinal Tumors
- Anti-allergic treatment
- (no location specified)
Jun 19, 2023
Gastrointestinal Tumors Trial in Zhengzhou (First dose, Second dose, The third dose)
Recruiting
- Gastrointestinal Tumors
- First dose
- +3 more
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Nov 22, 2023
Gastrointestinal Anastomosis Using MonoPlus® Suture
Recruiting
- Gastrointestinal Stromal Tumors
- +6 more
-
Sabadell, Cataluña, Spain
- +1 more
Jan 31, 2023
Colorectal Cancer, Advanced Adenocarcinoma, Hyperplastic Polyp Trial in Jinan (Multigene Methylation Detection Kit)
Completed
- Colorectal Cancer
- +5 more
- Multigene Methylation Detection Kit
-
Jinan, Shandong, ChinaShandong Cancer Hospital and Institute
Oct 19, 2022
Pancreatic Tumor, Digestive System Tumor, Tumors by Site Trial
Not yet recruiting
- Pancreatic Neoplasm
- +7 more
- (no location specified)
Apr 19, 2022
Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,
Completed
- Colorectal Cancer
- +12 more
- Anlotinib Hydrochloride
- +2 more
-
Hangzhou, Zhejiang, China
- +1 more
Jul 12, 2022
